Treatments of PC3 cells with a combination of PN1 and TRAIL recombinant proteins significantly reduced tumor growth in xenografts (Figure 1D–1E), suggesting a potent sensitization of prostate tumor cells to death signals. The gene discussed is TNFSF10; the disease is prostate neoplasm.